Semax is a synthetic neuropeptide derived from ACTH (4-10) with nootropic, neuroprotective, and neuroregenerative properties.
Overview
Semax is a heptapeptide and a synthetic analogue of a fragment of adrenocorticotropic hormone (ACTH), specifically ACTH (4-10), with the amino acid sequence Met-Glu-His-Phe-Pro-Gly-Pro (MEHFPGP). Unlike full ACTH, Semax retains neurotrophic effects without triggering hormonal side effects such as elevated cortisol. It was first developed in Russia in the 1980s for treating stroke, brain injury, and cognitive disorders and has been approved for clinical use in Russia and Ukraine.
Mechanism of Action
Semax exerts its effects primarily through modulation of brain-derived neurotrophic factor (BDNF), enhancing neuronal survival, synaptic plasticity, and neurogenesis. It also influences dopaminergic and serotonergic neurotransmission, which supports mood, focus, and motivation. Additional mechanisms may involve interaction with melanocortin receptors and inhibition of enzymes that degrade endogenous regulatory peptides, though the exact pathways are still under investigation.
Benefits and Therapeutic Uses
Semax has a broad range of effects, including:
- Cognitive enhancement: Improves memory, attention, learning, and mental clarity, particularly under stress or fatigue.
- Neuroprotection: Protects neurons from oxidative stress, ischemia, and neurodegenerative processes.
- Mood regulation: Exhibits anxiolytic and antidepressant-like effects by modulating neurotransmitters.
- Stroke and brain injury recovery: Supports neurological function and recovery post-ischemia.
- Potential cardiovascular benefits: Reduces oxidative stress and supports vascular function, potentially lowering heart disease risk.
- Other clinical applications: Studied for ADHD, Parkinson’s disease, Alzheimer’s disease, optic nerve atrophy, and cognitive decline.
-
Administration
Semax is typically administered intranasally, which allows rapid absorption into the brain and maximizes cognitive benefits. Injectable forms are also available, often compounded alongside Selank, another cognitive-enhancing peptide. Intranasal administration has been shown in animal studies to improve learning and memory more effectively than systemic injection.
Safety and Side Effects
Semax is generally well-tolerated, with minimal side effects reported in clinical studies. Because it does not trigger full ACTH hormonal activity, it avoids common endocrine-related side effects. However, as with all peptides, proper dosing and medical supervision are recommended, especially for research or therapeutic use outside of Russia and Ukraine.
Summary
Semax is a unique neuropeptide that enhances cognitive function, protects the brain, and supports recovery from neurological injury. Its ability to modulate BDNF, dopamine, and serotonin makes it a promising agent for nootropic and therapeutic applications, particularly in conditions involving cognitive decline, stress, or neurodegeneration.
